View in EDS HTML Full Text PDF Full Text

Overcoming resistance in advanced urothelial carcinoma: mechanisms of escape from antibody-drug conjugates and FGFR3 inhibition.

Saved in:
Bibliographic Details
Title: Overcoming resistance in advanced urothelial carcinoma: mechanisms of escape from antibody-drug conjugates and FGFR3 inhibition.
Authors: Wummer B; Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States., Schwartz M; Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States., Ciuro J; Emory University Winship Cancer Institute, Atlanta, GA, United States., Ahmed S; Emory University Winship Cancer Institute, Atlanta, GA, United States., Joshi SS; Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States., Narayan VM; Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States., Carthon BC; Emory University Winship Cancer Institute, Atlanta, GA, United States., Bilen MA; Emory University Winship Cancer Institute, Atlanta, GA, United States., Brown JT; Emory University Winship Cancer Institute, Atlanta, GA, United States.
Source: Frontiers in oncology [Front Oncol] 2025 Dec 02; Vol. 15, pp. 1654771. Date of Electronic Publication: 2025 Dec 02 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41409251
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Overcoming resistance in advanced urothelial carcinoma: mechanisms of escape from antibody-drug conjugates and FGFR3 inhibition.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wummer+B%22">Wummer B</searchLink>; Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Schwartz+M%22">Schwartz M</searchLink>; Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Ciuro+J%22">Ciuro J</searchLink>; Emory University Winship Cancer Institute, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Ahmed+S%22">Ahmed S</searchLink>; Emory University Winship Cancer Institute, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Joshi+SS%22">Joshi SS</searchLink>; Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Narayan+VM%22">Narayan VM</searchLink>; Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Carthon+BC%22">Carthon BC</searchLink>; Emory University Winship Cancer Institute, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Bilen+MA%22">Bilen MA</searchLink>; Emory University Winship Cancer Institute, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Brown+JT%22">Brown JT</searchLink>; Emory University Winship Cancer Institute, Atlanta, GA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Dec 02; Vol. 15, pp. 1654771. <i>Date of Electronic Publication: </i>2025 Dec 02 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41409251
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1654771
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1654771
    Titles:
      – TitleFull: Overcoming resistance in advanced urothelial carcinoma: mechanisms of escape from antibody-drug conjugates and FGFR3 inhibition.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wummer B
      – PersonEntity:
          Name:
            NameFull: Schwartz M
      – PersonEntity:
          Name:
            NameFull: Ciuro J
      – PersonEntity:
          Name:
            NameFull: Ahmed S
      – PersonEntity:
          Name:
            NameFull: Joshi SS
      – PersonEntity:
          Name:
            NameFull: Narayan VM
      – PersonEntity:
          Name:
            NameFull: Carthon BC
      – PersonEntity:
          Name:
            NameFull: Bilen MA
      – PersonEntity:
          Name:
            NameFull: Brown JT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 12
              Text: 2025 Dec 02
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1